Almotriptan Malate

CAS 154323-57-6 7 FDA-DMF suppliersSmall Molecule

Overview

Almotriptan Malate is a selective serotonin receptor agonist used to treat acute migraine attacks. It works by stimulating specific serotonin receptors in the brain, resulting in the constriction of dilated blood vessels.

API suppliers (9)

Suppliers of Almotriptan Malate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • JBC Pharmaceuticals Ltd.United Kingdom1 active DMF
  • MSN Laboratories Private LimitedIndia1 active DMF
  • JBC Pharmaceuticals Ltd.United Kingdom1 active DMF
  • MATRIX PHARMACORP PRIVATE LTD1 active DMF
  • MATRIX PHARMACORP PRIVATE LTD1 active DMF
  • JBC Pharmaceuticals Ltd.United Kingdom1 active DMF
  • MATRIX PHARMACORP PRIVATE LTD1 active DMF
  • MSN Laboratories Private LimitedIndia1 active DMF
  • APOTEX PHARMACHEM INC

Therapeutic areas

NeurologyPain Management

Related APIs

Pregabalin
40 suppliers
Rizatriptan Benzoate
22 suppliers
Cannabidiol
19 suppliers
Milnacipran Hydrochloride
12 suppliers
Eletriptan Hydrobromide
8 suppliers
Tizanidine Hydrochloride
7 suppliers
Frovatriptan Succinate
3 suppliers
Rimabotulinumtoxinb
2 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo